Toucan Capital Corp. is a venture capital firm specializing in investing in seed, early stage, growth capital, and select late stage investments as part of a larger investment syndicate.

The firm does not invest in diagnostics and tools-based companies; companies involved in healthcare services; automotive and other large or stationary applications of fuel cells; and enterprise software and other general software. It prefers to invest in novel classes of therapeutics and new emerging technologies.

The firm primarily focuses on the life sciences and advanced technology sectors. Within the life sciences sector, investments are sought in companies involved in therapeutics, biologics, medical devices, immune therapy, regenerative medicines, stem cells, and cell therapies and tissue engineering. Within the advanced technologies sector, it seeks to invest in emerging nanotechnologies including advanced materials and sensors, fuel cells and advanced batteries for mobile applications, information security, integrity assurance, and privacy.

The firm invests in companies based across the United States and is especially active in the Mid-Atlantic region. It typically invests between $.01 million and $5 million in initial financing and participates in follow on investments as the lead or co-lead investor. The firm typically invests in a company's first institutional financing. Toucan Capital Corp. was founded in 1998 and is based in Bethesda, Maryland.